Table 1 Clinico-pathological parameters of 108 SD-BLCA samples analysed in this study by immunohistochemistry
From: Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
Categorisation | na analysable | % | |
|---|---|---|---|
Parameter: | |||
Age at diagnosis: | median: 67.5 years | ||
(range 33–88) | |||
< 67.5 years | 53 | 49.1 | |
≥67.5 years | 53 | 49.1 | |
na | 2 | 1.8 | |
Gender | male | 52 | 48.1 |
female | 53 | 49.1 | |
na | 3 | 2.8 | |
Tumour subtype | UC/SCC | 45 | 41.7 |
SCC | 63 | 58.3 | |
Histological tumor gradeb | G1 | 1 | 0.9 |
G2 | 29 | 26.9 | |
G3 | 73 | 67.6 | |
G4 | 1 | 0.9 | |
na | 4 | 3.7 | |
Tumour stagec | pTx | 6 | 5.6 |
pT1 | 1 | 0.9 | |
pT2 | 13 | 12.1 | |
pT3 | 70 | 64.8 | |
pT4 | 18 | 16.6 | |
Lymph node status | negative (pN0) | 66 | 61.0 |
positive (pN1 + pN2) | 21 | 19.5 | |
na | 21 | 19.5 | |